ArticleFrontiers in physiology2021

Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19.

Luca Sala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.